WO2007057748A3 - Use of colostrum for the prophylaxis of influenza syndromes - Google Patents
Use of colostrum for the prophylaxis of influenza syndromes Download PDFInfo
- Publication number
- WO2007057748A3 WO2007057748A3 PCT/IB2006/003222 IB2006003222W WO2007057748A3 WO 2007057748 A3 WO2007057748 A3 WO 2007057748A3 IB 2006003222 W IB2006003222 W IB 2006003222W WO 2007057748 A3 WO2007057748 A3 WO 2007057748A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colostrum
- prophylaxis
- syndromes
- influenza
- influenza syndromes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Use of colostrum as an active principle for preparing pharmaceutical compositions for the prevention of influenza syndromes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2005A002204 | 2005-11-18 | ||
| IT002204A ITMI20052204A1 (en) | 2005-11-18 | 2005-11-18 | USE OF COLOSTRO FOR THE PROPHYLAXIS OF INFLUENCIAL SYNDRONS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007057748A2 WO2007057748A2 (en) | 2007-05-24 |
| WO2007057748A3 true WO2007057748A3 (en) | 2007-09-27 |
Family
ID=38049013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2006/003222 Ceased WO2007057748A2 (en) | 2005-11-18 | 2006-11-15 | Use of colostrum for the prophylaxis of influenza syndromes |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | ITMI20052204A1 (en) |
| WO (1) | WO2007057748A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2701032C (en) * | 2007-09-27 | 2021-01-26 | Amgen Inc. | Pharmaceutical formulations |
| WO2010053833A1 (en) | 2008-11-04 | 2010-05-14 | Vymedic, Llc | Antiviral supplement formulations |
| WO2011130800A1 (en) * | 2010-04-23 | 2011-10-27 | Probiotec Limited | Eczema treatment |
| US20130034541A1 (en) * | 2010-04-23 | 2013-02-07 | Probiotec Limited | Pharmaceutical compositions |
| CN103025346A (en) * | 2010-04-23 | 2013-04-03 | 普若拜特有限公司 | Cold treatment |
| WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
| CN101912394B (en) * | 2010-08-06 | 2013-11-06 | 岳茂兴 | Medicinal composition for treating coagulopathy haemorrhage and application thereof |
| EP2854848B1 (en) * | 2012-05-25 | 2016-10-26 | Gottfried Himmler | Secretory immunoglobulin deficiency treatment and prophylaxis |
| WO2014022886A1 (en) | 2012-08-08 | 2014-02-13 | Fischer Karen Jane | A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient |
| BR112015030767B1 (en) | 2013-06-10 | 2021-03-30 | N.V. Nutricia | USE OF A COMPOSITION |
| US10279013B2 (en) | 2013-12-19 | 2019-05-07 | Puretein Bioscience Llc | Methods for treating an animal |
| CA2970539A1 (en) * | 2014-12-16 | 2016-06-23 | Puretein Bioscience Llc. | Methods for increasing serum igf-1 in an animal |
| US20240058385A1 (en) * | 2022-08-09 | 2024-02-22 | Core Consumer Healthcare LLC | Anti-viral compositions and methods |
-
2005
- 2005-11-18 IT IT002204A patent/ITMI20052204A1/en unknown
-
2006
- 2006-11-15 WO PCT/IB2006/003222 patent/WO2007057748A2/en not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| ANIANSSON G ET AL: "ANTI-ADHESIVE ACTIVITY OF HUMAN CASEIN AGAINST STREPTOCOCCUS PNEUMONIAE AND HAEMOPHILUS INFLUENZAE", MICROBIAL PATHOGENESIS, ACADEMIC PRESS LIMITED, NEW YORK, NY, US, vol. 8, no. 5, 1 May 1990 (1990-05-01), pages 315 - 323, XP000674222, ISSN: 0882-4010 * |
| CESARONE M R ET AL: "Prevention of flu episodes with colostrum: Comparison with vaccination. The epidemiological study in San Valentino", GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, vol. 164, no. 3, June 2005 (2005-06-01), pages 163 - 169, XP009084541, ISSN: 0393-3660 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20052204A1 (en) | 2007-05-19 |
| WO2007057748A2 (en) | 2007-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008115281A3 (en) | Compounds for treating viral infections | |
| IL187999A0 (en) | Compositions for the treatment of persistent infections | |
| WO2011002808A8 (en) | Hcv protease inhibitors and uses thereof | |
| WO2008006528A3 (en) | Pharmaceutical compositions comprising levetiracetam | |
| WO2008127364A3 (en) | Antiviral compounds and use thereof | |
| WO2008013838A3 (en) | Pyridizinone derivatives | |
| WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| WO2010039237A8 (en) | Compounds for inflammation and immune-related uses | |
| WO2010111640A3 (en) | Anti-influenza formulations and methods | |
| WO2008045507A3 (en) | Substituted tetracycline compounds for treatment of bacillus anthracis infections | |
| WO2007057748A3 (en) | Use of colostrum for the prophylaxis of influenza syndromes | |
| WO2009115084A3 (en) | Pyrrolopyrimidine derivatives, and use thereof | |
| WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
| WO2009105969A8 (en) | Epothilone analogues, their pharmaceutical compositions, their use and their preparations | |
| WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| WO2008154234A3 (en) | Extended release formulation of nevirapine | |
| WO2006096518A3 (en) | Improved gacyclidine formulations | |
| WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
| WO2008137134A3 (en) | Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide | |
| WO2008081268A3 (en) | Pharmaceutical compositions of entacapone | |
| WO2007065595A3 (en) | Xanthine derivatives, processes for preparing them and their uses | |
| WO2007075794A3 (en) | Oral formulations comprising tigecycline | |
| WO2007070562A3 (en) | Non-hygroscopic compositions of enterostatin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06820895 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06820895 Country of ref document: EP Kind code of ref document: A2 |